RU2019116689A3 - - Google Patents

Download PDF

Info

Publication number
RU2019116689A3
RU2019116689A3 RU2019116689A RU2019116689A RU2019116689A3 RU 2019116689 A3 RU2019116689 A3 RU 2019116689A3 RU 2019116689 A RU2019116689 A RU 2019116689A RU 2019116689 A RU2019116689 A RU 2019116689A RU 2019116689 A3 RU2019116689 A3 RU 2019116689A3
Authority
RU
Russia
Application number
RU2019116689A
Other languages
Russian (ru)
Other versions
RU2019116689A (ru
RU2799564C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019116689A publication Critical patent/RU2019116689A/ru
Publication of RU2019116689A3 publication Critical patent/RU2019116689A3/ru
Application granted granted Critical
Publication of RU2799564C2 publication Critical patent/RU2799564C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2019116689A 2016-11-16 2017-11-15 Кристаллические формы ингибитора magl RU2799564C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662423126P 2016-11-16 2016-11-16
US62/423,126 2016-11-16
PCT/US2017/061875 WO2018093953A1 (en) 2016-11-16 2017-11-15 Crystalline forms of a magl inhibitor

Publications (3)

Publication Number Publication Date
RU2019116689A RU2019116689A (ru) 2020-12-17
RU2019116689A3 true RU2019116689A3 (cg-RX-API-DMAC10.html) 2021-02-26
RU2799564C2 RU2799564C2 (ru) 2023-07-06

Family

ID=

Also Published As

Publication number Publication date
EP3541807A4 (en) 2020-04-22
SI3541807T1 (sl) 2022-01-31
PL3541807T3 (pl) 2022-01-17
EP3964503C0 (en) 2023-11-08
HRP20211863T1 (hr) 2022-03-04
CL2019001340A1 (es) 2019-10-04
JP2022084717A (ja) 2022-06-07
NI201900053A (es) 2019-10-30
MA46866A (fr) 2021-06-02
CN110291083B (zh) 2022-06-17
MX2022000249A (es) 2022-02-03
PE20191239A1 (es) 2019-09-16
DK3541807T3 (da) 2021-12-06
GEP20237559B (en) 2023-10-25
JP7042548B2 (ja) 2022-03-28
PT3541807T (pt) 2021-12-09
RS62665B1 (sr) 2021-12-31
US20220235037A1 (en) 2022-07-28
MA58133B1 (fr) 2024-02-29
MX389459B (es) 2025-03-20
EP3964503A1 (en) 2022-03-09
PL3964503T3 (pl) 2024-04-02
KR20190077561A (ko) 2019-07-03
AU2017361257B2 (en) 2022-02-10
EP3964503B1 (en) 2023-11-08
CA3043610A1 (en) 2018-05-24
JP7350117B2 (ja) 2023-09-25
CY1124870T1 (el) 2022-11-25
GEAP202315091A (en) 2023-05-10
RS65016B1 (sr) 2024-01-31
PH12019501068A1 (en) 2019-08-19
CO2019005045A2 (es) 2019-05-31
EP3541807B1 (en) 2021-09-29
JOP20190109A1 (ar) 2019-05-09
HUE064559T2 (hu) 2024-03-28
LT3541807T (lt) 2021-12-27
CN115093382A (zh) 2022-09-23
US20200190063A1 (en) 2020-06-18
UA124585C2 (uk) 2021-10-13
NZ753241A (en) 2021-06-25
ECSP19035171A (es) 2019-05-31
SMT202100675T1 (it) 2022-01-10
RU2019116689A (ru) 2020-12-17
US11993588B2 (en) 2024-05-28
US11142517B2 (en) 2021-10-12
ZA201903093B (en) 2020-11-25
CR20190242A (es) 2019-07-09
ES2900016T3 (es) 2022-03-15
MY199386A (en) 2023-10-25
EA201991086A1 (ru) 2019-11-29
MA46866B1 (fr) 2021-11-30
CN110291083A (zh) 2019-09-27
TN2019000151A1 (en) 2020-10-05
SMT202300494T1 (it) 2024-01-10
CY1126586T1 (el) 2026-02-25
IL266548A (en) 2019-07-31
JP2019537596A (ja) 2019-12-26
WO2018093953A1 (en) 2018-05-24
MX2019005767A (es) 2019-12-05
DOP2019000120A (es) 2019-09-30
BR112019010003A2 (pt) 2019-08-20
ES2966939T3 (es) 2024-04-25
AU2017361257A1 (en) 2019-05-30
JOP20190109B1 (ar) 2022-09-15
HUE056973T2 (hu) 2022-04-28
HRP20231697T1 (hr) 2024-03-15
EP3541807A1 (en) 2019-09-25
KR102508739B1 (ko) 2023-03-09

Similar Documents

Publication Publication Date Title
BR112019002665A2 (cg-RX-API-DMAC10.html)
BR112018004986A2 (cg-RX-API-DMAC10.html)
BR112019008105A2 (cg-RX-API-DMAC10.html)
BR112019009366A2 (cg-RX-API-DMAC10.html)
BR112019001429A2 (cg-RX-API-DMAC10.html)
BR212018070320U2 (cg-RX-API-DMAC10.html)
BR112019011044B1 (pt) Compostos de pirazol substituído, seu uso, e composição farmacêutica
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112018069468B1 (pt) Uso de um agente indutor da imunidade
BR112019006736A2 (cg-RX-API-DMAC10.html)
CN303634689S (zh) 电脑机箱(umx3)
CN303623839S (zh) 型材(ca085b00211)
CN303623188S (zh) 直驱智能剑杆织机(tt-858)
CN303617299S (zh) 轮胎
CN303566450S (zh) 空调室外机
CN303628246S (zh) 用于手机的图形用户界面
CN303553797S (zh) 热风梳
CN303536045S (zh) 嫁衣(15)
CN303536549S (zh) 背提包(wb08009)
CN303536110S (zh) 眼罩(花纹)
CN303536111S (zh) 眼罩(条纹)